1. Home
  2. GROY vs RGNX Comparison

GROY vs RGNX Comparison

Compare GROY & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gold Royalty Corp.

GROY

Gold Royalty Corp.

HOLD

Current Price

$4.05

Market Cap

618.0M

Sector

N/A

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$13.85

Market Cap

661.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GROY
RGNX
Founded
2020
2008
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
618.0M
661.2M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
GROY
RGNX
Price
$4.05
$13.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
7
Target Price
$5.00
$30.29
AVG Volume (30 Days)
3.7M
612.2K
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,464,000.00
$161,318,000.00
Revenue This Year
$71.94
$132.80
Revenue Next Year
$66.48
$48.47
P/E Ratio
N/A
N/A
Revenue Growth
86.30
91.30
52 Week Low
$1.16
$5.04
52 Week High
$4.49
$13.99

Technical Indicators

Market Signals
Indicator
GROY
RGNX
Relative Strength Index (RSI) 53.12 63.20
Support Level $3.96 $12.61
Resistance Level $4.49 $13.42
Average True Range (ATR) 0.25 0.82
MACD -0.01 0.07
Stochastic Oscillator 53.54 93.12

Price Performance

Historical Comparison
GROY
RGNX

About GROY Gold Royalty Corp.

Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: